ReadCrystal

ReadCrystal is based on the internationally leading MicroED drug discovery platform to develop First-in-Class small molecule targeted innovative drugs. The team began developing MicroED technology at Stockholm University in Sweden in 2007. This technology was recognized as one of the top ten scientific breakthroughs of 2018 by Science magazine and represents a revolutionary new technology in the field of drug discovery. The team has published numerous world-class scientific papers in this field, including articles in Nature, Science, and Cell.